The fragile X premutation presenting as essential tremor

Archives of Neurology

Volumn 60, Issue 1, 2003, Pages 117-121

  Leehey, Maureen A ^a   Munhoz, Renato P ^a   Lang, Anthony E ^a   Brunberg, James A ^a   Grigsby, Jim ^a   Greco, Claudia ^a   Jacquemont, Sebastian ^a   Tassone, Flora ^a   Lozano, A M ^a   Hagerman, Paul J ^a   Hagerman, Randi J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; CASE REPORT; COGNITIVE DEFECT; ESSENTIAL TREMOR; FRAGILE X SYNDROME; GAIT DISORDER; GENE MUTATION; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; TANDEM REPEAT;

EID: 0037229944     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.1.117     Document Type: Article

References (30)

1. Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001;57:127-130.
2. Fahn S, Tolosa E, Marin C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. Baltimore, Md: Urban & Schwarzenberg; 1998:225-234.
3. Luria AR. Higher Cortical Functions in Man. 2nd ed. New York, NY: Basic Books; 1980.
4. Tassone F, Hagerman RJ, Taylor AK, Hagerman PJ. A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA. J Med Genet. 2001;38:453-456.
5. Tassone F, Hagerman RJ, Iklé DN, et al. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet. 1999;84:250-261.
6. Verkerk AJ, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-914.
7. Yu S, Pritchard M, Kremer E, et al. Fragile X genotype characterized by an unstable region of DNA. Science. 1991;252:1179-1181.
8. Oberlè I, Rousseau F, Heitz D, et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science. 1991;252:1097-1102.
9. Pieretti M, Zhang FP, Fu YH, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991;66:817-822.
10. Hagerman RJ. The physical and behavioral phenotype: In Hagerman RJ, Hagerman PJ, eds. Fragile X Syndrome: Diagnosis, Treatment, and Research. Baltimore, Md: Johns Hopkins University Press; 2002:3-109.
11. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. Prevalence of carriers of premutation-size alleles of the FMRI gene-and implications for the population genetics of the fragile X syndrome. Am J Hum Genet. 1995;57:1006-1018.
12. Rousseau F, Morel M-L, Rouillard P, Khandjian EW, Morgan K. Surprisingly low prevalence of FMR1 premutation among males from the general population [abstract]. Am J Hum Genet. 1996;59:1069.
13. Pesso R, Berkenstadt M, Cuckle H, Peleg L, Frydman M, Barkai G. Screening for fragile X syndrome in women of reproductive age. Prenat Diagn. 2000;20:611-614.
14. Toledano-Alhadef H, Basel-Vanagaite L, Magal N, et al. Fragile X carrier screening and the prevalence of premutation and full mutation carriers in Israel. Am J Hum Genet. 2001;69:351-360.
15. Tassone F, Hagerman RJ, Chamberlain WD, Hagerman PJ. Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet. 2000;97:195-203.
16. Tassone F, Hagerman RJ, Loesch DZ, Lachiewicz A, Taylor AK, Hagerman PJ. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet. 2000;94:232-236.
17. Loesch DZ, Hay DA, Mulley J. Transmitting males and carrier females in fragile X - revisited. Am J Med Genet. 1994;51:392-399.
18. Riddle JE, Cheema A, Sobesky WE, et al. Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard. 1998;102:590-601.
19. Tassone F, Hagerman RJ, Taylor AK, et al. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet. 2000;91:144-152.
20. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study - preliminary data. Am J Med Genet. 1999;83:322-325.
21. Brundberg JA, Jacquement S, Hagerman RJ, et al. Fragile X premutation carriers: characteristic MR imaging findings in adult males with progressive cerebellar and cognitive dysfunction. Am J Neuroradiol. In press.
22. Greco CM, Hagerman RJ, Tassone F, et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain. In press.
23. Kurtze JF. The current neurological burden of illness and injury in the United States. Neurology. 1982;32:1207-1214.
24. Brin MF, Koller W. Epidemiology and genetics of essential tremor. Mov Disord. 1998;13(suppl 3):55-63.
25. Lou JS, Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology. 1991;41:234-238.
26. Brennan K, Jurewicz E, Ford B, Pullman S, Louis E. Is essential tremor predominately a kinetic or a postural tremor? a clinical and electrophysiological study. Mov Disord. 2002;17:313-316.
27. Hubble JP, Busenbark KL, Pahwa R, Lyons K, Koller WC. Clinical expression of essential tremor: effects of gender and age. Mov Disord. 1997;12:969-972.
28. Stolze H, Petersen G, Raethjen J, Wenzelburger R, Deuschl G. The gait disorder of advanced essential tremor. Brain. 2001;124:2278-2286.
29. Gasparini M, Bonifati V, Fabrizio E, et al. Frontal lobe dysfunction in essential tremor: a preliminary study. J Neurol. 2001;248:399-402.
30. Lombardi WJ, Woolston DJ, Roberts JW, Gross RE. Cognitive deficits in patients with essential tremor. Neurology. 2001;57:785-790.